Recombinant Human Tau-F/2N4R Protein，His

The Tau-F/2N4R recombinant protein is an essential focus of research in the context of neurodegenerative diseases, particularly Alzheimer's disease and frontotemporal dementia. Tau protein, a microtubule-associated protein that stabilizes microtubules in neurons, exists in multiple isoforms resulting from alternative splicing of the MAPT gene. The 2N4R isoform, characterized by its two N-terminal and four repeat domains, is particularly implicated in tauopathies due to its propensity to form toxic aggregates. These aggregates disrupt neuronal function and contribute to cell death. The Tau-F/2N4R construct serves as a valuable tool for studying the aggregation properties and pathobiology of tau in vitro and in vivo. Understanding the mechanisms by which Tau-F/2N4R aggregates form, how they interact with other cellular components, and their role in neurodegeneration is crucial for developing therapeutic strategies. Research on this recombinant protein also facilitates the screening of potential drugs aimed at preventing or reversing tau aggregation, ultimately contributing to novel approaches for treating tau-related disorders. Thus, the study of Tau-F/2N4R not only illuminates fundamental aspects of tau pathology but also holds promise for advancing therapeutic interventions in neurodegenerative diseases.